Summary

The United Kingdom faces a substantial burden of respiratory disorders, which encompasses a range of conditions that impact the respiratory system, including but not limited to chronic obstructive pulmonary disease, asthma, pneumonia, and interstitial lung diseases. Respiratory disease is one of the biggest killers in the United Kingdom, encompassing diseases such as lung cancer and asthma. Asthma is a very common long-term lung condition. According to the NHS England, Asthma is the most common long-term medical condition in children in the UK, with around one in 11 children and young people living with asthma. The UK has one of the highest prevalence, emergency admission and death rates for childhood asthma in Europe. 1 million children in the UK are receiving treatment for asthma. As the burden of respiratory diseases grows, so does the demand for respiratory care devices. The need for advanced treatments and management solutions, such as inhalers, nebulizers, oxygen concentrators, and ventilators, is on the rise. This surge in demand is driven by a collective recognition of the importance of effective respiratory care in improving patient outcomes and enhancing their quality of life. The United Kingdom's healthcare system, with its commitment to innovation and adherence to rigorous regulatory standards, is poised to meet this growing demand with high-quality, cutting-edge respiratory care devices. Thus, the emergence of this demand is not only a response to the mounting burden of respiratory disorders but also a reflection of the nation's commitment to addressing this critical health issue and improving the respiratory health of its population. Also, as per the Occupational Lung Disease statistics in Great Britain, 2021, an estimate of 17,000 new cases of breathing and lung problems were recorded each year in the country, with the condition being caused as a result of either work or worsened by their work. Such high incidences of respiratory problems in the nation are expected to propel the growth of the United Kingdom respiratory devices market over the forecast period.

According to the research report "United Kingdom Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the market is anticipated to reach around USD 2 Billion by 2028. In the United Kingdom, the manufacturing of respiratory care devices is experiencing a notable upswing, concurrent with the emergence of a burgeoning market for these essential healthcare tools. This dual trend is shaped by a variety of interrelated factors. The increasing prevalence of respiratory health concerns, along with a heightened awareness of their significance, has propelled a growing demand for advanced solutions designed to enhance patient well-being. This demographic shift, in conjunction with the broader public awareness, has resulted in a sustained and expanding need for an array of respiratory care devices. Furthermore, the COVID-19 pandemic has amplified the importance of these devices as they are integral in addressing severe respiratory distress, leading to intensified investments in healthcare infrastructure and the strategic stockpiling of vital equipment. Moreover, innovative advancements in respiratory care technology and strong collaboration between academia and industry have positioned the United Kingdom as a key player in the global respiratory care devices market. The expansion of this sector not only enhances the nation's healthcare capabilities but also fuels economic growth and fosters a positive outlook for the future of respiratory care in the United Kingdom and its global contributions to improved patient outcomes and medical technology. The respiratory care devices market in the United Kingdom is currently in a phase of significant expansion, fueled by a convergence of crucial factors that are shaping the healthcare landscape in the country.

In the United Kingdom, the market for respiratory equipment is meticulously segmented based on product types into four distinct categories; therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories. Among these categories, therapeutic devices stand out as the dominant force, boasting a significant market share. This prominence can be attributed to the ever-growing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea in the UK. Therapeutic devices, which include devices like inhalers, nebulizers, and positive airway pressure machines, play a crucial role in managing and improving the quality of life for individuals with these conditions, driving their widespread adoption in the market. Notably, the market landscape is not solely defined by therapeutic devices; monitoring and diagnostic devices also wield substantial influence, collectively commanding a significant share. Monitoring devices, such as pulse oximeters and spirometers, are essential tools for tracking the vital parameters of patients with respiratory issues. They provide healthcare professionals and patients alike with valuable real-time data, enabling early intervention and better disease management. Meanwhile, diagnostic devices, including advanced imaging technologies and pulmonary function tests, facilitate accurate and timely diagnosis, a critical step in ensuring appropriate treatment. The market's diverse and dynamic nature is further enriched by the consumables and accessories category, which encompasses items like masks, filters, and tubing necessary for the functioning of respiratory equipment.

In the United Kingdom's respiratory equipment market, disease indication serves as a pivotal factor in the segmentation, encompassing a range of conditions including chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other respiratory conditions. COPD emerges as the front-runner, significantly dominating the market due to its high prevalence and the substantial demand for advanced respiratory equipment for its management. This chronic and progressive lung disease necessitates a wide array of therapeutic, monitoring, and diagnostic devices, which contributes significantly to the market's overall revenue. However, the market's strength isn't solely reliant on COPD; it also draws substantial support from sleep apnea, asthma, infectious diseases, and other disease indications. Sleep apnea, a condition characterized by interrupted breathing during sleep, has gained prominence as awareness grows regarding its potential health risks, driving the demand for specialized devices such as continuous positive airway pressure (CPAP) machines. Asthma, a widespread respiratory disorder, also plays a vital role in shaping the market, with inhalers and nebulizers being integral components of asthma management. Infectious diseases, particularly in the context of respiratory infections such as COVID-19, have bolstered the demand for diagnostic and monitoring equipment, underlining their significant market share. Moreover, the "other disease indications" category encompasses a range of respiratory ailments, collectively contributing to the market's robustness.

The United Kingdom's respiratory equipment market extends its segmentation to encompass a variety of end users, with a diverse range of institutions and facilities relying on these critical devices for the management and treatment of respiratory conditions. Among the key end users, hospitals emerge as the primary driving force in this market, with their extensive patient population and the need for comprehensive respiratory care. Hospitals are equipped with a wide array of respiratory devices, including ventilators, oxygen delivery systems, and sophisticated monitoring equipment, to provide immediate and intensive care to patients with severe respiratory ailments. The significant market share held by hospitals is reflective of the pivotal role they play in addressing acute and chronic respiratory issues, serving as hubs of expertise and medical resources for those in need. In addition to hospitals, ambulatory care centers (ACCs) are integral contributors to the respiratory equipment market. ACCs are uniquely positioned to provide outpatient respiratory care, catering to patients who require ongoing monitoring, diagnosis, and treatment for their conditions. These centers offer a convenient and accessible option for individuals seeking respiratory healthcare outside of traditional hospital settings. ACCs are equipped with a range of monitoring and diagnostic devices to facilitate efficient and effective care delivery, contributing significantly to the market's growth. Home care settings represent an emerging and increasingly important segment within the respiratory equipment market. This growth can be attributed to the growing trend of shifting healthcare delivery from institutional settings to patients' homes, where they can receive personalized care and maintain a higher quality of life. Patients with chronic respiratory conditions, such as COPD or sleep apnea, often benefit from the use of respiratory devices in the comfort of their homes. This trend has fuelled the demand for portable and user-friendly respiratory equipment, including home ventilators, CPAP machines, and oxygen concentrators. The home care setting not only enhances patient comfort and convenience but also helps reduce the burden on hospitals and healthcare costs, making it a significant market share holder.

Considered in this report:
• Geography: United Kingdom
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• United Kingdom Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents